Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells

In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma

(2015) Maria Teresa Di Martino et al.   Oncotarget

Effects of miR-155 Antisense Oligonucleotide on Breast Carcinoma Cell Line MDA-MB-157 and Implanted Tumors

(2013) Shu-Rong Zheng et al.   Asian Pacific Journal of Cancer Prevention

Aberrant microRNA expression in multiple myeloma

(2013) Konstantinos Dimopoulos et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The Role of CD19 and CD27 in the Diagnosis of Multiple Myeloma by Flow Cytometry

(2012) Elisa Cannizzo et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

(2012) Y-S Zang et al.   CANCER GENE THERAPY

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

(2012) M. T. Di Martino et al.   CLINICAL CANCER RESEARCH

MicroRNAs in the Pathobiology of Multiple Myeloma

(2012) Marta Lionetti et al.   CURRENT CANCER DRUG TARGETS

Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication

(2012) Yoshimasa Saito et al.   PLoS One

MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1

(2012) Rui Yao et al.   PLoS One

Deregulated microRNAs in multiple myeloma

(2011) Leonidas Benetatos et al.   CANCER

MicroRNA therapeutics

(2011) J A Broderick et al.   GENE THERAPY

Silencing of microRNA families by seed-targeting tiny LNAs

(2011) Susanna Obad et al.   NATURE GENETICS

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway

(2010) R. Krishnan Kutty et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene

(2010) S. Jiang et al.   CANCER RESEARCH

Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis

(2010) Yumin Li et al.   Hematology

Targeting of SMAD5 links microRNA-155 to the TGF-  pathway and lymphomagenesis

(2010) D. Rai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

(2009) M. Lionetti et al.   BLOOD

Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe

(2009) B. B. Aggarwal et al.   CLINICAL CANCER RESEARCH

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

microRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia

(2008) A. M. Roccaro et al.   BLOOD

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

(2008) Gema Mateo et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

(2008) F. Pichiorri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of microRNA with antisense oligonucleotides

(2007) Christine C. Esau   METHODS